Form 4 for YCBD cbdMD, Inc.

Accepted 2022-08-11 00:00:00 ET · period of report 2022-08-09 · accession 0001437749-22-020197 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
D	2022-08-11	2022-08-09	YCBD	Swift Sibyl Nichole	Dir	A - Grant	$0.00	+5,000	10.2K	+95%	$0
D	2022-08-11	2022-08-09	YCBD	Swift Sibyl Nichole	Dir	A - Grant	—	+30.0K	30.0K	New	—

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Stock	2022-08-09	A	A	5,000	$0.00	10,250	D	—	—	(F1) The restricted shares of common stock were issued under the 2015 Equity Compensation Plan as compensation to the Reporting Person for her services on the Issuer's Board of Directors for the Board term beginning August 9, 2022. The issuance was exempt from Section 16(b) under the Securities Exchange Act of 1934 by virtue of Rule 16b-3 promulgated thereunder as it was approved in advance by the Issuer's Compensation, Corporate Governance and Nominating Committee, which is comprised of four non-employee directors. The shares vested upon issuance.
2	Derivative	Stock Options (Right to Buy)	2022-08-09	A	A	30,000	—	30,000	D	$0.57 · 2022-08-09 to 2027-08-09	30,000 Common Stock	(F2) The stock options were issued under the 2015 Equity Compensation Plan as compensation to the Reporting Person for her services on the Issuer's Board of Directors for the Board term beginning August 9, 2022. The issuance was exempt from Section 16(b) under the Securities Exchange Act of 1934 by virtue of Rule 16b-3 promulgated thereunder as it was approved in advance by the Issuer's Compensation, Corporate Governance and Nominating Committee, which is comprised of four non-employee directors. and the options are fully vested as of the date of issuance. (F3) Not applicable.